Identity
Argireline is acetyl hexapeptide-8, investigated in topical wrinkle formulations.
Selected study only; not a complete clinical review.
Peptide library
Argireline
Your guide to this compound.
Mechanism illustrationEnlarge
Evidence in perspective
A short topical-emulsion study addresses that formulation and cosmetic measurement. It does not show equivalence to botulinum toxin, delivery into deeper muscles or a benefit for injected acetyl hexapeptide.
About this assessment
Existing source snapshot critically reassessed.
Based on the selected source scope described in this profile, often an indexed abstract. Full methods and clinician sign-off remain pending; no systematic-review claim.
Editorial assessment · 2026-09-07
Who was studied
Laboratory experiments and a short topical study in women.
What the sources found
The tested emulsion reduced measured wrinkle depth over 30 days; this does not establish equivalence to injected botulinum toxin.
Regulatory scope
Current authorization for the exact product and jurisdiction was not independently checked in this snapshot. A clinical trial is not marketing authorization.
What remains unknown
Selected indexed primary-study abstract reviewed. Full methods, bias, all safety outcomes, product stability, current jurisdictional authorization and a comprehensive literature search remain outstanding. This is not a complete clinical review.
How it works
Argireline is acetyl hexapeptide-8, investigated in topical wrinkle formulations.
The study-specific findings below distinguish biological activity from demonstrated treatment benefit.
Limited clinical evidence
The catalog describes a limited clinical evidence base. Small or uncontrolled studies may not separate treatment effects from chance, placebo effects or bias.
Reported adverse effects
- Reported tolerability cannot establish the safety of other formulations or injection.
Selected study only; not a complete clinical review.
Contraindications
- A complete contraindication and interaction review remains outstanding.
Limited clinical evidence
The catalog describes a limited clinical evidence base. Small or uncontrolled studies may not separate treatment effects from chance, placebo effects or bias.
Sources used for this snapshot
Claim-by-claim evidence
Benefits
The tested emulsion reduced measured wrinkle depth over 30 days; this does not establish equivalence to injected botulinum toxin.
Selected study only; not a complete clinical review.
Adverseeffects
Reported tolerability cannot establish the safety of other formulations or injection.
Selected study only; not a complete clinical review.
References
A synthetic hexapeptide (Argireline) with antiwrinkle activity. 2002.
PMID: 18498523
Catalog review date: Sep 7, 2026. This date alone does not establish independent clinical review.